Latest Safety News

Page 89 of 146
Perseus Mining delivered a strong June 2025 quarter, hitting production targets and maintaining a robust cash position of US$827 million, while progressing major projects including the Nyanzaga Gold Project in Tanzania.
Maxwell Dee
Maxwell Dee
28 July 2025
Korvest has reported record full-year earnings for FY25, driven by a surge in major project revenue and strong cash flow, while approving a significant expansion of its Kilburn manufacturing facility.
Victor Sage
Victor Sage
25 July 2025
Korvest Ltd reported a strong FY25 with revenues up 16.2% and net profit after tax rising 19.1%, supported by major infrastructure projects and operational resilience. The company declared a fully franked final dividend plus a special dividend, while advancing plans to expand its Kilburn manufacturing site.
Victor Sage
Victor Sage
25 July 2025
Kinetiko Energy has spudded its third gas production test well at Brakfontein and signed a non-binding term sheet with FFS Refiners to co-develop a pilot LNG plant, backed by a recent $2.2 million capital raise.
Maxwell Dee
Maxwell Dee
25 July 2025
Supply Network Limited reported solid FY2025 results with 15% revenue growth and expanded its branch footprint, setting sights on further growth despite upcoming operational changes.
Victor Sage
Victor Sage
25 July 2025
Cycliq Group Ltd reported a 7% increase in customer receipts to $4.8 million for FY2025, alongside a positive net operating cash inflow, driven by strong Q4 sales and new digital initiatives.
Victor Sage
Victor Sage
25 July 2025
Kingston Resources has completed the $95 million sale of its Misima Gold Project, bolstering its balance sheet and enabling accelerated growth at its Mineral Hill mine in NSW. The company reports strong operational progress and promising high-grade drilling results.
Maxwell Dee
Maxwell Dee
25 July 2025
Neurizon Therapeutics has formally responded to the FDA's clinical hold on its lead ALS drug NUZ-001, submitting new animal safety data. The company aims to join the HEALEY ALS Platform Trial by late 2025, pending regulatory approval.
Ada Torres
Ada Torres
25 July 2025
Dimerix has secured a significant licensing agreement with Amicus Therapeutics for its kidney disease drug candidate DMX-200 in the US, receiving a US$30 million upfront payment and advancing its Phase 3 trial with FDA endorsement of a key clinical endpoint.
Ada Torres
Ada Torres
25 July 2025
Newmont Corporation reported a robust second quarter in 2025, driven by higher gold prices, successful divestitures of non-core assets, and strong operational performance, reinforcing its financial strength and strategic focus.
Maxwell Dee
Maxwell Dee
25 July 2025
Vection Technologies has secured $1 million in new AI contracts, including a significant third deal with Area 12 Consulting, boosting their partnership to $3.6 million in just ten weeks.
Sophie Babbage
Sophie Babbage
24 July 2025
Karoon Energy reported a 25% jump in net revenue interest production for Q2 2025, driven by operational recovery and the Baúna FPSO acquisition. The company also advanced its Neon development with a significant resource upgrade.
Maxwell Dee
Maxwell Dee
24 July 2025